SDBN August Event: The Transformation of the Biotech Business Model

Our August event will feature an interactive panel in which we?ll discuss the areas you are interested in hearing about: Green technology, Translational Research/Medicine, and Drug Development.

Transformation of Biotech Panel Members:

* Aileen Alvarado-Swaisgood, President, Molecular Alliance (moderator)
* Nigel Beeley, CEO, ENRQI
* Roy Cosan, Director, Strategic Planning & Alliance Management, External Research and Early Development, Johnson & Johnson PRD
* Ali Esteghlalian, Product Manager, Industrial Enzymes & Principal Scientist, Enzyme Applications, Verenium
* Gary Firestein, Professor of Medicine, Chief, Division of Rheumatology Allergy & Immunology, Dean, Translational Medicine, UCSD
* Bruce Steel, Chief Business Officer, Anaphore

[[Click Here For More Information]]